Literature DB >> 22623750

Selenium and prostate cancer: the puzzle isn't finished yet.

Erin L Richman, June M Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22623750      PMCID： PMC3374730          DOI： 10.3945/ajcn.112.042119

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN： 0002-9165            Impact factor:   7.045


× No keyword cloud information.
  10 in total

Review 1.  Selenium and prostate cancer: systematic review and meta-analysis.

Authors:  Rachel Hurst; Lee Hooper; Teresa Norat; Rosa Lau; Dagfinn Aune; Darren C Greenwood; Rui Vieira; Rachel Collings; Linda J Harvey; Jonathan A C Sterne; Rebecca Beynon; Jelena Savović; Susan J Fairweather-Tait
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

2.  Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis.

Authors:  Emily C Chiang; Shuren Shen; Seema S Kengeri; Huiping Xu; Gerald F Combs; J Steven Morris; David G Bostwick; David J Waters
Journal:  Dose Response       Date:  2009-12-21       Impact factor: 2.658

3.  Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Scott M Lippman; Phyllis J Goodman; Eric A Klein; Howard L Parnes; Ian M Thompson; Alan R Kristal; Regina M Santella; Jeffrey L Probstfield; Carol M Moinpour; Demetrius Albanes; Philip R Taylor; Lori M Minasian; Ashraful Hoque; Sarah Moody Thomas; John J Crowley; J Michael Gaziano; Janet L Stanford; Elise D Cook; Neil E Fleshner; Michael M Lieber; Philip J Walther; Fadlo R Khuri; Daniel D Karp; Gary G Schwartz; Leslie G Ford; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

4.  A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.

Authors:  Kathryn L Penney; Fredrick R Schumacher; Haojie Li; Peter Kraft; J Steven Morris; Tobias Kurth; Lorelei A Mucci; David J Hunter; Philip W Kantoff; Meir J Stampfer; Jing Ma
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-27

5.  Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.

Authors:  Haojie Li; Philip W Kantoff; Edward Giovannucci; Michael F Leitzmann; J Michael Gaziano; Meir J Stampfer; Jing Ma
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

6.  Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men.

Authors:  Astrid Steinbrecher; Catherine Méplan; John Hesketh; Lutz Schomburg; Tobias Endermann; Eugène Jansen; Björn Akesson; Sabine Rohrmann; Jakob Linseisen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-17       Impact factor: 4.254

7.  Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.

Authors:  Anna J Duffield-Lillico; Mary E Reid; Bruce W Turnbull; Gerald F Combs; Elizabeth H Slate; Lori A Fischbach; James R Marshall; Larry C Clark
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-07       Impact factor: 4.254

8.  Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.

Authors:  A J Duffield-Lillico; B L Dalkin; M E Reid; B W Turnbull; E H Slate; E T Jacobs; J R Marshall; L C Clark
Journal:  BJU Int       Date:  2003-05       Impact factor: 5.588

9.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Scott M Lippman; Eric A Klein; Phyllis J Goodman; M Scott Lucia; Ian M Thompson; Leslie G Ford; Howard L Parnes; Lori M Minasian; J Michael Gaziano; Jo Ann Hartline; J Kellogg Parsons; James D Bearden; E David Crawford; Gary E Goodman; Jaime Claudio; Eric Winquist; Elise D Cook; Daniel D Karp; Philip Walther; Michael M Lieber; Alan R Kristal; Amy K Darke; Kathryn B Arnold; Patricia A Ganz; Regina M Santella; Demetrius Albanes; Philip R Taylor; Jeffrey L Probstfield; T J Jagpal; John J Crowley; Frank L Meyskens; Laurence H Baker; Charles A Coltman
Journal:  JAMA       Date:  2008-12-09       Impact factor: 56.272

10.  Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.

Authors:  June M Chan; William K Oh; Wanling Xie; Meredith M Regan; Meir J Stampfer; Irena B King; Miyako Abe; Philip W Kantoff
Journal:  J Clin Oncol       Date:  2009-06-15       Impact factor: 44.544
  10 in total
  9 in total

1.  Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

Authors:  Alan R Kristal; Amy K Darke; J Steven Morris; Catherine M Tangen; Phyllis J Goodman; Ian M Thompson; Frank L Meyskens; Gary E Goodman; Lori M Minasian; Howard L Parnes; Scott M Lippman; Eric A Klein
Journal:  J Natl Cancer Inst       Date:  2014-02-22       Impact factor: 13.506

2.  Characterization of selenium-enriched wheat by agronomic biofortification.

Authors:  Catarina Galinha; María Sánchez-Martínez; Adriano M G Pacheco; Maria do Carmo Freitas; José Coutinho; Benvindo Maçãs; Ana Sofia Almeida; María Teresa Pérez-Corona; Yolanda Madrid; Hubert T Wolterbeek
Journal:  J Food Sci Technol       Date:  2014-08-13       Impact factor: 2.701

Review 3.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

4.  Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.

Authors:  Philip W Kantoff; Lorelei A Mucci; June M Chan; Amy K Darke; Kathryn L Penney; Catherine M Tangen; Phyllis J Goodman; Gwo-Shu Mary Lee; Tong Sun; Sam Peisch; Alex M Tinianow; James M Rae; Eric A Klein; Ian M Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-06       Impact factor: 4.254

5.  Induction of reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells.

Authors:  Trinath P Das; Suman Suman; Chendil Damodaran
Journal:  Mol Carcinog       Date:  2013-03-08       Impact factor: 4.784

6.  A Pan-Cancer Analysis of the Role of Selenoprotein P mRNA in Tumorigenesis.

Authors:  Yanni Yang; Daning Li; Wentao Wu; Dingxing Huang; Haishi Zheng; Yirixiati Aihaiti
Journal:  Int J Gen Med       Date:  2021-10-30

7.  Adherence to dietary and lifestyle recommendations and prostate cancer risk in the prostate testing for cancer and treatment (ProtecT) trial.

Authors:  Vanessa Er; J Athene Lane; Richard M Martin; Pauline Emmett; Rebecca Gilbert; Kerry N L Avery; Eleanor Walsh; Jenny L Donovan; David E Neal; Freddie C Hamdy; Mona Jeffreys
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-13       Impact factor: 4.254

8.  Neutralization by metal ions of the toxicity of sodium selenide.

Authors:  Marc Dauplais; Myriam Lazard; Sylvain Blanquet; Pierre Plateau
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

Review 9.  Is selenium a potential treatment for cancer metastasis?

Authors:  Yu-Chi Chen; K Sandeep Prabhu; Andrea M Mastro
Journal:  Nutrients       Date:  2013-04-08       Impact factor: 5.717
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.